Literature DB >> 15136631

PET performance measurements for an LSO-based combined PET/CT scanner using the National Electrical Manufacturers Association NU 2-2001 standard.

Yusuf E Erdi1, Sadek A Nehmeh, Tim Mulnix, John L Humm, Charles C Watson.   

Abstract

UNLABELLED: Results of performance measurements for a lutetium oxyorthosilicate (LSO)-based PET/CT scanner using new National Electrical Manufacturers Association (NEMA) NU 2-2001 standards are reported.
METHODS: Performance measurements following the NU 2-2001 standards were performed on an LSO-based PET/CT scanner. In addition, issues associated with the application of the NEMA standard to LSO-based tomographs in the presence of intrinsic radiation are discussed.
RESULTS: We report on some difficulties experienced in following the suggested NEMA measurement techniques and describe alternative approaches. Measurements with the new standard (as compared with NU-1994) incorporate the effects of activity outside the scanner and facilitate measurements of the entire axial field of view. Realistic clinical conditions are also simulated in image quality measurements of a torso phantom.
CONCLUSION: We find that, with appropriate modifications, NU 2-2001 can be successfully applied to LSO-based scanners.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136631

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  Performance of the new generation of whole-body PET/CT scanners: Discovery STE and Discovery VCT.

Authors:  M Teräs; T Tolvanen; J J Johansson; J J Williams; J Knuuti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07-28       Impact factor: 9.236

2.  PET/CT fusion viewing software for use with picture archiving and communication systems.

Authors:  Ki Chun Im; Ik Soo Choi; Jin-Sook Ryu; Gi Seoung Eo; Jae Seung Kim; Dae Hyuk Moon
Journal:  J Digit Imaging       Date:  2009-08-06       Impact factor: 4.056

3.  PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants.

Authors:  Katia Parodi; Harald Paganetti; Ethan Cascio; Jacob B Flanz; Ali A Bonab; Nathaniel M Alpert; Kevin Lohmann; Thomas Bortfeld
Journal:  Med Phys       Date:  2007-02       Impact factor: 4.071

4.  Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer.

Authors:  Ja Seong Bae; Byung Joo Chae; Woo Chan Park; Jeong Soo Kim; Sung Hoon Kim; Sang Seol Jung; Byung Joo Song
Journal:  World J Surg Oncol       Date:  2009-08-10       Impact factor: 2.754

5.  Quantitative accuracy of PET/CT for image-based kinetic analysis.

Authors:  Youngho Seo; Boon-Keng Teo; Mohiuddin Hadi; Carole Schreck; Stephen L Bacharach; Bruce H Hasegawa
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

Review 6.  Advances in rubidium PET and integrated imaging with CT angiography.

Authors:  Mark F Smith
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

7.  Whole-body PET acceptance test in 2D and 3D using NEMA NU 2-2001 protocol.

Authors:  Shamurailatpam Dayananda Sharma; R Prasad; Bina Shetye; V Rangarajan; D Deshpande; S K Shrivastava; K A Dinshaw
Journal:  J Med Phys       Date:  2007-10

8.  Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 2.0.

Authors:  Hiroyoshi Fukukita; Kazufumi Suzuki; Keiichi Matsumoto; Takashi Terauchi; Hiromitsu Daisaki; Yasuhiko Ikari; Naoki Shimada; Michio Senda
Journal:  Ann Nucl Med       Date:  2014-05-24       Impact factor: 2.668

9.  Importance of Defect Detectability in Positron Emission Tomography Imaging of Abdominal Lesions.

Authors:  Shozo Yamashita; Kunihiko Yokoyama; Masahisa Onoguchi; Haruki Yamamoto; Tetsu Nakaichi; Shiro Tsuji; Kenichi Nakajima
Journal:  Asia Ocean J Nucl Med Biol       Date:  2015

10.  The effect of modern PET technology and techniques on the EANM paediatric dosage card.

Authors:  John Dickson; Uta Eberlein; Michael Lassmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-15       Impact factor: 10.057

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.